Coltrin achieves results for its clients
Results for Our Clients
Braeburn Pharmaceuticals logo

Coltrin branded Braeburn Pharmaceuticals CEO Behshad Sheldon as a leader in medical innovation and a key voice on social justice issues relating to the stigma of opioid addiction and its treatment. Coltrin also publicized Probuphine, the first-ever 6-month implant for opioid addiction, in top-tier print, broadcast, in digital markets in both national and local publications. 

Probuphine implant on FOX Business
Coverage consisted of business and consumer press including NBC Nightly News, CNBC, FOX
Business, Inc. Magazine, The New York Times, USA Today, WebMD, Marketwatch, Institutional Investor Magazine, etc.

»TheStreet July 21, 2017
»BioSpace July 21, 2017
»Mornings with Maria - FOX Business April 27, 2017
»Inc. Magazine December 20, 2016
»WKRC - CBS Cincinnati October 21, 2016
»Fast Company August 3, 2016
»NBC Nightly News June 19, 2016
»CNBC - Squawk on the Street May 17, 2016
»WCAU NBC10 Philadelphia April 3, 2016
»NBC Nightly News March 15, 2016
»KSL-TV March 4, 2016
»New York Times January 12, 2016

»Additional Coltrin-placed media for Braeburn Pharmaceuticals

This site was made with Mobirise